<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle">
<p class="DocumentTitle"><strong>EPINEPHRINE- epinephrine hydrochlorideÂ injection, solutionÂ </strong><br>Valesco Pharmaceuticals LLC.<br></p>
<p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. <a href="http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/default.htm">For further information about unapproved drugs, click here.</a></p>
</div>
<h1></h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
<h1></h1>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="Lc38c9cf0-0398-4c90-9d1f-98cd1f0e1489"></a><a name="section-1"></a><p></p>
<h1></h1>
<p class="First"><span class="Bold">1:1000</span></p>
<p><span class="Bold">Rx only</span></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="L2f6726b8-83f0-4c57-aa72-86b3972eaf36"></a><a name="section-2"></a><p></p>
<h1>DESCRIPTION </h1>
<p class="First">Epinephrine Injection, USP is a sterile, nonpyrogenic solution intended for subcutaneous or intramuscular injection. When diluted, it may also be administered intracardially or intravenously. Each mL contains: Epinephrine 1 mg (as the Hydrochloride), Water for Injection q.s. Sodium Chloride added for isotonicity, Chlorobutanol 0.5% (a chloroform derivative) as a preservative and Sodium Metabisulfite not more than 0.15% as an antioxidant. Epinephrine is the active principle of the adrenal medulla, chemically described as (-)-3,4-Dihydroxy-Î±-[(methylamino)methyl)]benzyl alcohol, and has the following structural formula:</p>
<p></p>
<p><img alt="epinephrine structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=3ed35d7d-616c-43cd-9776-705821afc1f0&amp;name=epinephrine%20structure.jpg"></p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="Lbc1bb0af-e324-4293-8643-8477dac9c7f8"></a><a name="section-3"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">Epinephrine is a sympathomimetic drug. It activates an adrenergic receptive mechanism on effector cells and imitates all actions of the sympathetic nervous system except those on the arteries of the face and sweat glands. Epinephrine acts on both alpha and beta receptors and is the most potent alpha receptor activator.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="Ld86a04f2-9c84-4adc-acfb-35725b9ded9c"></a><a name="section-4"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">In general, the most common uses of epinephrine are to relieve <span class="product-label-link" type="condition" conceptid="4158346" conceptname="Respiratory distress">respiratory distress</span> due to <span class="product-label-link" type="condition" conceptid="256717" conceptname="Bronchospasm">bronchospasm</span>, to provide rapid relief of <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity reactions</span> to drugs and other allergens, and to prolong the action of infiltration anesthetics. Its cardiac effects may be of use in restoring cardiac rhythm in <span class="product-label-link" type="condition" conceptid="321042" conceptname="Cardiac arrest">cardiac arrest</span> due to various causes, but it is not used in <span class="product-label-link" type="condition" conceptid="316139" conceptname="Heart failure">cardiac failure</span> or in hemorrhagic, traumatic, or <span class="product-label-link" type="condition" conceptid="198571" conceptname="Cardiogenic shock">cardiogenic shock</span>.</p>
<p>Epinephrine is used as a hemostatic agent. It is also used in treating mucosal congestion of <span class="product-label-link" type="condition" conceptid="256439" conceptname="Allergic rhinitis due to pollen">hay fever</span>, <span class="product-label-link" type="condition" conceptid="4320791" conceptname="Rhinitis">rhinitis</span> and <span class="product-label-link" type="condition" conceptid="260123" conceptname="Acute sinusitis">acute sinusitis</span>; to relieve bronchial <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthmatic</span> paroxysms; in <span class="product-label-link" type="condition" conceptid="135360" conceptname="Syncope">syncope</span> due to <span class="product-label-link" type="condition" conceptid="320744" conceptname="Complete atrioventricular block">complete heart block</span> or carotid sinus <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span>; for symptomatic relief of <span class="product-label-link" type="condition" conceptid="432522" conceptname="Transfusion reaction due to serum protein reaction">serum sickness</span>, <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span>, <span class="product-label-link" type="condition" conceptid="432791" conceptname="Angioedema">angioneurotic edema</span>; for resuscitation in <span class="product-label-link" type="condition" conceptid="321042" conceptname="Cardiac arrest">cardiac arrest</span> following anesthetic <span class="product-label-link" type="condition" conceptid="440279" conceptname="Accident">accidents</span>; in simple (open angle) <span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">glaucoma</span>; for relaxation of uterine musculature and to inhibit uterine contractions. Epinephrine injection can be utilized to prolong the action of local anesthetics (see CONTRAINDICATIONS).</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="L9026aa8b-1b41-4f84-a16d-54a0299b0d83"></a><a name="section-5"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">Epinephrine is contraindicated in narrow angle (congestive) <span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">glaucoma</span>, <span class="product-label-link" type="condition" conceptid="201965" conceptname="Shock">shock</span>, during general anesthesia with halogenated hydrocarbons or cyclopropane and in individuals with organic <span class="product-label-link" type="condition" conceptid="4080670" conceptname="Brain damage">brain damage</span>. Epinephrine is also contraindicated with local anesthesia of certain areas, e.g., fingers, toes, because of the danger of <span class="product-label-link" type="condition" conceptid="4137788" conceptname="Vascular constriction">vasoconstriction</span> producing <span class="product-label-link" type="condition" conceptid="4032013" conceptname="Desquamation">sloughing</span> of tissue; in labor because it may delay the second stage; in <span class="product-label-link" type="condition" conceptid="314658" conceptname="Cardiomegaly">cardiac dilatation</span> and coronary insufficiency.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="L33e7a419-db24-4342-b5f7-4fcfae820d26"></a><a name="section-6"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">Administer with caution to elderly people; to those with cardiovascular disease, <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span>, <span class="product-label-link" type="condition" conceptid="201820" conceptname="Diabetes mellitus">diabetes</span>, or <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span>; in psychoneurotic individuals; and in pregnancy.</p>
<p>Patients with long-standing bronchial <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthma</span> and <span class="product-label-link" type="condition" conceptid="4169883" conceptname="Emphysema">emphysema</span> who have developed degenerative heart disease should be administered the drug with extreme caution.</p>
<p>Overdosage or inadvertent intravenous injection of epinephrine may cause cerebrovascular <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">hemorrhage</span> resulting from the sharp <span class="product-label-link" type="condition" conceptid="141693" conceptname="Elevated blood-pressure reading without diagnosis of hypertension">rise in blood pressure</span>.</p>
<p>Fatalities may also result from <span class="product-label-link" type="condition" conceptid="4078925" conceptname="Pulmonary edema">pulmonary edema</span> because of the peripheral constriction and cardiac stimulation produced. Rapidly acting vasodilators, such as nitrites, or alpha blocking agents may counteract the marked pressor effects of epinephrine.</p>
<p>Epinephrine is the preferred treatment of serious allergic or other emergency situations even though this product contains sodium metabisulfite, a sulfite that may in other products cause allergic-type reactions including anaphylactic symptoms or life-threatening or less severe <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthmatic</span> episodes in certain susceptible persons. The alternative to using epinephrine in a life-threatening situation may not be satisfactory. The presence of a sulfite in this product should not deter administration of the drug for treatment of serious allergic or other emergency situations.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="L3c3ef0bb-72c9-40f3-841c-bd1427a52d91"></a><a name="section-7"></a><p></p>
<h1>PRECAUTIONS</h1>
<p class="First"><span class="Bold">General</span></p>
<p>Epinephrine injection should be protected from exposure to light. Do not remove vial from carton until ready to use. The solution should not be used if it is pinkish or darker than slightly yellow or if it contains a precipitate.</p>
<p>Epinephrine is readily destroyed by alkalies and oxidizing agents. In the latter category are oxygen, chlorine, bromine, iodine, permanganates, chromates, nitrites, and salts of easily reducible metals, especially iron.</p>
<p><span class="Bold">Drug Interactions</span></p>
<p>Use of epinephrine with excessive doses of digitalis, mercurial diuretics, or other drugs that sensitize the heart to <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">arrhythmias</span> is not recommended. <span class="product-label-link" type="condition" conceptid="321318" conceptname="Angina pectoris">Anginal pain</span> may be induced when coronary insufficiency is present.</p>
<p>The effects of epinephrine may be potentiated by tricyclic antidepressants; certain antihistamines, e.g., diphenhydramine, tripelennamine, d-chlorpheniramine, and sodium l-thyroxine.</p>
<p><span class="Bold">Pregnancy</span></p>
<p><span class="Italics">Teratogenic Effects</span></p>
<p>Pregnancy Category C. Epinephrine has been shown to be teratogenic in rats when given in doses about 25 times the human dose. There are no adequate and well-controlled studies in pregnant women. Epinephrine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.</p>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="L699b3a70-e983-46a8-a26b-b7faa3ce3ff5"></a><a name="section-8"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">Transient and minor side effects of <span class="product-label-link" type="condition" conceptid="441542" conceptname="Anxiety">anxiety</span>, <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, <span class="product-label-link" type="condition" conceptid="4029621" conceptname="Fear">fear</span>, and <span class="product-label-link" type="condition" conceptid="315078" conceptname="Palpitations">palpitations</span> often occur with therapeutic doses, especially in hyperthyroid individuals. Repeated local injections can result in <span class="product-label-link" type="condition" conceptid="4280654" conceptname="Necrosis">necrosis</span> at sites of injection from vascular constriction. â€œEpinephrine-fastnessâ€? can occur with prolonged use.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="L456fb790-4035-43dd-8e71-b14fbb9189ee"></a><a name="section-9"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">Subcutaneously or intramuscularly âˆ’ 0.2 to 1 mL (mg). Start with a small dose and increase if required.</p>
<p>Note: The subcutaneous is the preferred route of administration. If given intramuscularly, injection into the buttocks should be avoided.</p>
<p>For bronchial <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthma</span> and certain allergic manifestations, e.g., <span class="product-label-link" type="condition" conceptid="432791" conceptname="Angioedema">angioedema</span>, <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span>, <span class="product-label-link" type="condition" conceptid="432522" conceptname="Transfusion reaction due to serum protein reaction">serum sickness</span>, <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylactic shock</span>, use epinephrine subcutaneously. For bronchial <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthma</span> in pediatric patients, administer 0.01 mg/kg or 0.3 mg/m2 to a maximum of 0.5 mg subcutaneously, repeated every four hours if required.</p>
<p>For cardiac resuscitation âˆ’ A dose of 0.5 mL (0.5 mg) diluted to 10 mL with sodium chloride injection can be administered intravenously or intracardially to restore myocardial contractility. External cardiac massage should follow intracardial administration to permit the drug to enter coronary circulation. The drug should be used secondarily to unsuccessful attempts with physical or electromechanical methods.</p>
<p>Store at 20Â°-25Â°C (68Â°-77Â°F); excursions permitted to 15Â°-30Â°C (59Â°-86Â°F) (See USP Controlled Room Temperature).</p>
<p><span class="Bold">â€‹Protect from light.</span></p>
<p>Parenteral drug products should be inspected visually for particulate matter and discoloration whenever solution and container permit.</p>
<p>â€‹</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="L2e8f01ca-aaff-4047-8801-cceb42cbb3ed"></a><a name="section-10"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">Epinephrine Injection, USP 1:1000 (1mg/mL)</p>
<p>NDC 44827-301-02Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â  30 mL Multiple Dose Vial</p>
<p>Rev 02/14</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="L777191a0-3689-486a-a612-ab85c917b255"></a><a name="section-11"></a><p></p>
<h1>PACKAGE LABEL.PRINCIPAL DISPLAY PANEL</h1>
<p class="First"><img alt="epinephrine_single_carton_Label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=3ed35d7d-616c-43cd-9776-705821afc1f0&amp;name=epinephrine_single_carton_Label.jpg"></p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>EPINEPHRINEÂ 		
					</strong><br><span class="contentTableReg">epinephrine injection, solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:44827-301</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAMUSCULAR, SUBCUTANEOUS, INTRAVENOUS</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>EPINEPHRINE HYDROCHLORIDE</strong> (EPINEPHRINE) </td>
<td class="formItem">EPINEPHRINE</td>
<td class="formItem">1Â mg Â inÂ 1Â mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SODIUM CHLORIDE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>CHLOROBUTANOL</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SODIUM METABISULFITE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:44827-301-02</td>
<td class="formItem">1  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">30 mL in 1 VIAL, MULTI-DOSE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">unapproved drug other</td>
<td class="formItem"></td>
<td class="formItem">03/01/1994</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler -Â </span>Valesco Pharmaceuticals LLC.
							(968729314)
						</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 2/2014<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>0691d246-5df7-4d84-bd2a-d10bb09db1a0</div>
<div>Set id: 3ed35d7d-616c-43cd-9776-705821afc1f0</div>
<div>Version: 3</div>
<div>Effective Time: 20140224</div>
</div>
</div>Â <div class="DistributorName">Valesco Pharmaceuticals LLC.</div></p>
</body></html>
